Nanotechnology in Cardiovascular Medicine

The term nanotechnology alludes to an extensive variety of advances which might majorly affect drug and particularly in the field of cardiovascular pharmaceutical. A portion of the exploration territories in cardiovascular medication conceivably influenced by the utilization of nanotechnology incorporate observing gadgets for the cardiovascular framework (bio sensors), heart valve prostheses, imaging innovation (contrast media), instruments and propelled materials for insignificant intrusive surgery, persistent medication application innovation, drug eluting stents, and mechanical help gadgets supporting the coming up short heart. The potential effect of nanotechnology on the future advancement of more complex mechanical help gadgets is a great sample to show the collaboration of various fortes to enhance such gadgets. The nanomedicine market came to $63.8 billion in 2010 and $72.8 billion in 2011. The business sector is relied upon to develop to $130.9 billion by 2016 at a compound yearly development rate (CAGR) of 12.5% between years 2011 and 2016.

  • Nano Cardiomyoplasty
  • Nano-carriers against atherosclerotic plaques
  • Polysaccharide Nanosystems for Future Progress in Cardiovascular Diseases
  • Transmyocardial Revascularization (TMR) by Medical Nanomaterials
  • Nano Artificial Heart Valve Surgery
  • Nanotechnology for Cardiac Tissue Regeneration

Related Conference of Nanotechnology in Cardiovascular Medicine

August 24-25, 2026

36th World Nano Conference

London, UK
September 21-22, 2026

39th International Conference on Neonatology and Perinatology

Barcelona, Spain
January 28-29, 2027

30th World Nanotechnology Congress

Singapore City, Singapore
February 18-19, 2027

27th World Congress on Neonatology and Pediatrics

Barcelona, Spain

Nanotechnology in Cardiovascular Medicine Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in